| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 124 | 2024 | 591 | 28.200 |
Why?
|
| Blood Preservation | 82 | 2024 | 263 | 20.230 |
Why?
|
| Metabolomics | 80 | 2024 | 527 | 15.330 |
Why?
|
| Metabolome | 47 | 2023 | 283 | 10.140 |
Why?
|
| Proteomics | 69 | 2024 | 843 | 8.860 |
Why?
|
| Erythrocyte Transfusion | 30 | 2023 | 186 | 7.260 |
Why?
|
| Proteome | 29 | 2023 | 339 | 5.490 |
Why?
|
| Glycolysis | 45 | 2023 | 227 | 5.150 |
Why?
|
| Shock, Hemorrhagic | 14 | 2023 | 193 | 5.030 |
Why?
|
| Blood Donors | 21 | 2024 | 89 | 5.030 |
Why?
|
| Oxidative Stress | 39 | 2022 | 1084 | 4.970 |
Why?
|
| Hemolysis | 22 | 2024 | 146 | 4.880 |
Why?
|
| Anemia, Sickle Cell | 12 | 2023 | 216 | 4.010 |
Why?
|
| Mass Spectrometry | 36 | 2020 | 633 | 3.750 |
Why?
|
| Energy Metabolism | 27 | 2022 | 729 | 3.520 |
Why?
|
| Blood Transfusion | 14 | 2023 | 276 | 3.450 |
Why?
|
| Pentose Phosphate Pathway | 16 | 2023 | 48 | 3.080 |
Why?
|
| Plasma | 9 | 2022 | 210 | 3.070 |
Why?
|
| Humans | 359 | 2024 | 114756 | 2.930 |
Why?
|
| Blood Proteins | 13 | 2020 | 232 | 2.790 |
Why?
|
| Hypoxia | 19 | 2023 | 957 | 2.710 |
Why?
|
| Glucosephosphate Dehydrogenase | 9 | 2022 | 37 | 2.670 |
Why?
|
| Animals | 178 | 2024 | 31761 | 2.600 |
Why?
|
| Blood Platelets | 15 | 2023 | 351 | 2.500 |
Why?
|
| Transfusion Medicine | 5 | 2023 | 8 | 2.430 |
Why?
|
| High-Throughput Screening Assays | 6 | 2021 | 123 | 2.220 |
Why?
|
| Amino Acids | 16 | 2023 | 448 | 2.150 |
Why?
|
| Membrane Lipids | 5 | 2021 | 87 | 2.080 |
Why?
|
| Leukemia, Myeloid, Acute | 20 | 2023 | 536 | 2.070 |
Why?
|
| Glucose | 20 | 2023 | 897 | 2.000 |
Why?
|
| Blood Banks | 8 | 2021 | 40 | 1.980 |
Why?
|
| Fatty Acids | 16 | 2024 | 382 | 1.950 |
Why?
|
| Purines | 11 | 2023 | 159 | 1.930 |
Why?
|
| Chromatography, High Pressure Liquid | 19 | 2020 | 472 | 1.920 |
Why?
|
| Wounds and Injuries | 10 | 2020 | 723 | 1.860 |
Why?
|
| Mice | 95 | 2024 | 14916 | 1.840 |
Why?
|
| Kynurenine | 9 | 2024 | 80 | 1.750 |
Why?
|
| Oxidation-Reduction | 29 | 2021 | 927 | 1.710 |
Why?
|
| Platelet Transfusion | 4 | 2023 | 64 | 1.670 |
Why?
|
| Glutathione | 18 | 2022 | 300 | 1.670 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 6 | 2023 | 13 | 1.640 |
Why?
|
| Cellular Reprogramming | 8 | 2021 | 84 | 1.630 |
Why?
|
| Meat | 5 | 2014 | 87 | 1.620 |
Why?
|
| Biomarkers | 30 | 2023 | 3416 | 1.560 |
Why?
|
| Male | 139 | 2024 | 55579 | 1.560 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 340 | 1.530 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 332 | 1.520 |
Why?
|
| Altitude Sickness | 6 | 2020 | 172 | 1.500 |
Why?
|
| Pandemics | 6 | 2023 | 1319 | 1.470 |
Why?
|
| Carbon | 7 | 2023 | 157 | 1.470 |
Why?
|
| Cryopreservation | 7 | 2018 | 92 | 1.450 |
Why?
|
| Pancreatic Neoplasms | 7 | 2023 | 732 | 1.450 |
Why?
|
| Muscle, Skeletal | 15 | 2024 | 1472 | 1.430 |
Why?
|
| Succinic Acid | 5 | 2020 | 44 | 1.390 |
Why?
|
| Lymph | 5 | 2016 | 40 | 1.350 |
Why?
|
| Blood Coagulation Disorders | 5 | 2023 | 192 | 1.310 |
Why?
|
| Mitochondria | 19 | 2022 | 751 | 1.280 |
Why?
|
| Female | 135 | 2023 | 59507 | 1.280 |
Why?
|
| Biochemistry | 4 | 2015 | 40 | 1.280 |
Why?
|
| Leukocyte Reduction Procedures | 6 | 2020 | 25 | 1.270 |
Why?
|
| Adult | 90 | 2023 | 30548 | 1.260 |
Why?
|
| Cattle | 11 | 2022 | 921 | 1.250 |
Why?
|
| Erythrocyte Membrane | 7 | 2022 | 50 | 1.240 |
Why?
|
| Sciuridae | 3 | 2020 | 142 | 1.240 |
Why?
|
| Oxygen | 16 | 2022 | 853 | 1.230 |
Why?
|
| Food Analysis | 3 | 2012 | 18 | 1.190 |
Why?
|
| Muscle Proteins | 6 | 2019 | 210 | 1.160 |
Why?
|
| Polyamines | 3 | 2022 | 35 | 1.150 |
Why?
|
| Drug Discovery | 4 | 2013 | 124 | 1.140 |
Why?
|
| Time Factors | 30 | 2021 | 6124 | 1.120 |
Why?
|
| Choline | 8 | 2022 | 106 | 1.110 |
Why?
|
| Lactic Acid | 7 | 2023 | 275 | 1.100 |
Why?
|
| Isotope Labeling | 3 | 2017 | 69 | 1.090 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 3 | 2021 | 22 | 1.090 |
Why?
|
| Interleukin-6 | 2 | 2020 | 675 | 1.080 |
Why?
|
| Neoplastic Stem Cells | 11 | 2023 | 334 | 1.070 |
Why?
|
| Aging | 14 | 2024 | 1620 | 1.070 |
Why?
|
| Liver | 16 | 2022 | 1631 | 1.060 |
Why?
|
| Hypertension, Pulmonary | 11 | 2023 | 1728 | 1.050 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2023 | 642 | 1.050 |
Why?
|
| Inflammation | 22 | 2024 | 2481 | 1.050 |
Why?
|
| Signal Transduction | 27 | 2023 | 4521 | 1.040 |
Why?
|
| Adenine | 4 | 2022 | 219 | 1.040 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2023 | 486 | 1.030 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2023 | 345 | 1.000 |
Why?
|
| Protein D-Aspartate-L-Isoaspartate Methyltransferase | 2 | 2023 | 5 | 1.000 |
Why?
|
| Alzheimer Disease | 4 | 2023 | 443 | 1.000 |
Why?
|
| Rh-Hr Blood-Group System | 2 | 2023 | 11 | 0.990 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 212 | 0.970 |
Why?
|
| Altitude | 4 | 2023 | 433 | 0.930 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2021 | 53 | 0.920 |
Why?
|
| Sodium Chloride | 3 | 2014 | 136 | 0.910 |
Why?
|
| Mice, Inbred C57BL | 34 | 2024 | 4710 | 0.910 |
Why?
|
| Adenosine Triphosphate | 13 | 2024 | 431 | 0.910 |
Why?
|
| Blood Group Antigens | 1 | 2023 | 14 | 0.910 |
Why?
|
| Hemoglobin SC Disease | 1 | 2023 | 15 | 0.900 |
Why?
|
| Reactive Oxygen Species | 11 | 2022 | 536 | 0.890 |
Why?
|
| Macrophages | 15 | 2023 | 1261 | 0.890 |
Why?
|
| Hypocalcemia | 1 | 2023 | 31 | 0.870 |
Why?
|
| Disease Models, Animal | 24 | 2023 | 3542 | 0.860 |
Why?
|
| Sickle Cell Trait | 1 | 2023 | 14 | 0.860 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2021 | 399 | 0.850 |
Why?
|
| Rejuvenation | 3 | 2022 | 14 | 0.850 |
Why?
|
| Neoplasms | 9 | 2024 | 2105 | 0.850 |
Why?
|
| Hibernation | 3 | 2020 | 72 | 0.840 |
Why?
|
| Cell Line, Tumor | 27 | 2023 | 2725 | 0.840 |
Why?
|
| Testosterone | 2 | 2023 | 343 | 0.840 |
Why?
|
| Citric Acid Cycle | 7 | 2021 | 43 | 0.830 |
Why?
|
| Tryptophan | 6 | 2021 | 135 | 0.830 |
Why?
|
| Equidae | 1 | 2022 | 4 | 0.830 |
Why?
|
| Organ Preservation Solutions | 9 | 2014 | 39 | 0.820 |
Why?
|
| Athletic Performance | 1 | 2023 | 54 | 0.820 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2020 | 282 | 0.820 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 136 | 0.800 |
Why?
|
| Erythropoietin | 1 | 2022 | 72 | 0.790 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 26 | 0.790 |
Why?
|
| Drosophila Proteins | 5 | 2024 | 163 | 0.790 |
Why?
|
| beta-Thalassemia | 4 | 2023 | 23 | 0.790 |
Why?
|
| Healthy Volunteers | 9 | 2022 | 197 | 0.780 |
Why?
|
| Isoaspartic Acid | 1 | 2021 | 3 | 0.780 |
Why?
|
| Carnitine | 5 | 2022 | 62 | 0.780 |
Why?
|
| Adaptation, Physiological | 5 | 2018 | 483 | 0.780 |
Why?
|
| Pyruvate Kinase | 5 | 2023 | 20 | 0.770 |
Why?
|
| Zika Virus | 1 | 2022 | 61 | 0.760 |
Why?
|
| Xanthine | 2 | 2020 | 7 | 0.750 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2021 | 2209 | 0.750 |
Why?
|
| Diethylhexyl Phthalate | 2 | 2023 | 9 | 0.740 |
Why?
|
| Bacterial Infections | 2 | 2021 | 219 | 0.740 |
Why?
|
| Lysophospholipids | 5 | 2023 | 65 | 0.740 |
Why?
|
| Blood Chemical Analysis | 3 | 2010 | 90 | 0.740 |
Why?
|
| Fatty Acid Desaturases | 1 | 2021 | 29 | 0.730 |
Why?
|
| Running | 2 | 2022 | 207 | 0.730 |
Why?
|
| Phosphates | 4 | 2023 | 158 | 0.730 |
Why?
|
| Zika Virus Infection | 1 | 2022 | 85 | 0.720 |
Why?
|
| Nitrogen | 3 | 2020 | 145 | 0.720 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 5 | 2023 | 245 | 0.720 |
Why?
|
| Pancreatic Cyst | 1 | 2021 | 48 | 0.720 |
Why?
|
| Cell Death | 2 | 2020 | 322 | 0.720 |
Why?
|
| Glucuronates | 1 | 2020 | 4 | 0.710 |
Why?
|
| Milk Proteins | 2 | 2010 | 36 | 0.710 |
Why?
|
| Coffee | 1 | 2020 | 10 | 0.710 |
Why?
|
| Adenosine | 14 | 2023 | 202 | 0.700 |
Why?
|
| Antineoplastic Agents | 11 | 2021 | 1895 | 0.700 |
Why?
|
| Torpor | 2 | 2020 | 14 | 0.690 |
Why?
|
| Taurine | 1 | 2020 | 41 | 0.680 |
Why?
|
| Caffeine | 1 | 2020 | 57 | 0.680 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 6 | 2020 | 172 | 0.680 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 592 | 0.680 |
Why?
|
| Thrombosis | 5 | 2023 | 297 | 0.670 |
Why?
|
| Brain Death | 3 | 2016 | 31 | 0.670 |
Why?
|
| Adenocarcinoma | 3 | 2019 | 801 | 0.670 |
Why?
|
| Physical Exertion | 1 | 2021 | 211 | 0.670 |
Why?
|
| Iron | 3 | 2018 | 234 | 0.670 |
Why?
|
| Parabiosis | 1 | 2019 | 12 | 0.670 |
Why?
|
| Endothelial Cells | 9 | 2023 | 681 | 0.670 |
Why?
|
| Gene Expression Regulation | 16 | 2021 | 2321 | 0.670 |
Why?
|
| Erythrocyte Deformability | 4 | 2023 | 12 | 0.660 |
Why?
|
| Oxidative Phosphorylation | 11 | 2022 | 156 | 0.660 |
Why?
|
| Asparagine | 2 | 2018 | 29 | 0.660 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2021 | 452 | 0.660 |
Why?
|
| 2,3-Diphosphoglycerate | 8 | 2023 | 29 | 0.660 |
Why?
|
| Temperature | 4 | 2021 | 575 | 0.660 |
Why?
|
| Erythrocyte Aging | 3 | 2017 | 6 | 0.660 |
Why?
|
| Refrigeration | 2 | 2017 | 11 | 0.660 |
Why?
|
| Arousal | 2 | 2020 | 152 | 0.650 |
Why?
|
| Citric Acid | 2 | 2016 | 30 | 0.650 |
Why?
|
| Proteostasis | 2 | 2020 | 20 | 0.650 |
Why?
|
| Lipid Metabolism | 11 | 2023 | 446 | 0.650 |
Why?
|
| Rats | 19 | 2023 | 4943 | 0.640 |
Why?
|
| Arginine | 5 | 2022 | 236 | 0.640 |
Why?
|
| Middle Aged | 52 | 2023 | 26757 | 0.630 |
Why?
|
| Citrates | 2 | 2017 | 43 | 0.630 |
Why?
|
| Drosophila melanogaster | 6 | 2024 | 191 | 0.630 |
Why?
|
| Aspartic Acid | 1 | 2018 | 77 | 0.620 |
Why?
|
| Blood Specimen Collection | 1 | 2018 | 31 | 0.620 |
Why?
|
| Complement System Proteins | 2 | 2021 | 285 | 0.620 |
Why?
|
| Blood Component Transfusion | 3 | 2015 | 75 | 0.620 |
Why?
|
| Gluconates | 1 | 2018 | 4 | 0.620 |
Why?
|
| Antacids | 1 | 2018 | 15 | 0.610 |
Why?
|
| Fetal Blood | 2 | 2010 | 270 | 0.610 |
Why?
|
| Extracellular Vesicles | 4 | 2023 | 83 | 0.610 |
Why?
|
| Blood Coagulation | 6 | 2023 | 217 | 0.600 |
Why?
|
| Guanosine | 1 | 2018 | 39 | 0.600 |
Why?
|
| Mesentery | 2 | 2014 | 53 | 0.590 |
Why?
|
| Hemoglobin, Sickle | 3 | 2023 | 14 | 0.590 |
Why?
|
| Hypoxanthine | 1 | 2017 | 9 | 0.590 |
Why?
|
| Apoptosis | 15 | 2022 | 2369 | 0.590 |
Why?
|
| Ischemic Preconditioning | 1 | 2018 | 28 | 0.590 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2023 | 300 | 0.590 |
Why?
|
| Prognosis | 6 | 2021 | 3334 | 0.590 |
Why?
|
| Swine | 6 | 2023 | 700 | 0.580 |
Why?
|
| Models, Biological | 8 | 2021 | 1630 | 0.580 |
Why?
|
| Betacoronavirus | 4 | 2020 | 252 | 0.570 |
Why?
|
| Resuscitation | 4 | 2022 | 247 | 0.570 |
Why?
|
| Metabolic Networks and Pathways | 8 | 2023 | 168 | 0.560 |
Why?
|
| RNA-Binding Proteins | 6 | 2023 | 344 | 0.560 |
Why?
|
| Leukemia | 4 | 2020 | 210 | 0.560 |
Why?
|
| Cadmium | 2 | 2015 | 58 | 0.560 |
Why?
|
| Kidney Transplantation | 15 | 2016 | 541 | 0.550 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1053 | 0.550 |
Why?
|
| Hemorrhage | 5 | 2023 | 618 | 0.550 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.550 |
Why?
|
| Mannitol | 3 | 2022 | 32 | 0.540 |
Why?
|
| Cellular Senescence | 2 | 2020 | 152 | 0.530 |
Why?
|
| Hemoglobins | 8 | 2022 | 314 | 0.530 |
Why?
|
| Exercise | 3 | 2023 | 1644 | 0.530 |
Why?
|
| Body Fluids | 2 | 2017 | 58 | 0.520 |
Why?
|
| Antioxidants | 5 | 2023 | 530 | 0.520 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 328 | 0.520 |
Why?
|
| Systems Biology | 2 | 2013 | 56 | 0.510 |
Why?
|
| Glutamine | 6 | 2023 | 91 | 0.510 |
Why?
|
| Metabolic Flux Analysis | 1 | 2015 | 7 | 0.510 |
Why?
|
| Fluid Therapy | 1 | 2016 | 122 | 0.500 |
Why?
|
| Acidosis | 1 | 2016 | 87 | 0.500 |
Why?
|
| Tissue Donors | 8 | 2016 | 317 | 0.500 |
Why?
|
| Acetaminophen | 3 | 2023 | 238 | 0.500 |
Why?
|
| Mutation | 13 | 2024 | 3350 | 0.500 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2022 | 151 | 0.500 |
Why?
|
| Sphingosine | 3 | 2023 | 33 | 0.490 |
Why?
|
| Ischemia | 2 | 2019 | 362 | 0.490 |
Why?
|
| Fibrinolysis | 4 | 2019 | 158 | 0.490 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 1868 | 0.490 |
Why?
|
| Cold Temperature | 6 | 2021 | 128 | 0.490 |
Why?
|
| Sulfonamides | 6 | 2020 | 445 | 0.490 |
Why?
|
| Blood Volume | 1 | 2015 | 59 | 0.490 |
Why?
|
| Sulfur | 3 | 2022 | 46 | 0.490 |
Why?
|
| Liver Transplantation | 14 | 2019 | 706 | 0.480 |
Why?
|
| Exercise Tolerance | 3 | 2023 | 213 | 0.480 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 447 | 0.480 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2021 | 144 | 0.470 |
Why?
|
| Lactates | 4 | 2023 | 79 | 0.470 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 654 | 0.460 |
Why?
|
| Precision Medicine | 4 | 2019 | 338 | 0.460 |
Why?
|
| Chromatography, Reverse-Phase | 2 | 2012 | 26 | 0.460 |
Why?
|
| Receptor, Adenosine A2B | 3 | 2021 | 32 | 0.460 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 7 | 0.460 |
Why?
|
| Octreotide | 1 | 2014 | 25 | 0.450 |
Why?
|
| Methionine | 3 | 2020 | 144 | 0.450 |
Why?
|
| Plant Transpiration | 1 | 2013 | 5 | 0.450 |
Why?
|
| Mustard Plant | 1 | 2013 | 2 | 0.450 |
Why?
|
| Substance P | 1 | 2014 | 44 | 0.450 |
Why?
|
| Biomedical Research | 3 | 2021 | 585 | 0.450 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 138 | 0.450 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 76 | 0.440 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2023 | 175 | 0.440 |
Why?
|
| Homeostasis | 8 | 2023 | 575 | 0.440 |
Why?
|
| Mice, Knockout | 12 | 2023 | 2582 | 0.440 |
Why?
|
| Bile Acids and Salts | 4 | 2023 | 172 | 0.440 |
Why?
|
| Cholestasis | 3 | 2021 | 224 | 0.440 |
Why?
|
| Interleukin-1beta | 6 | 2021 | 370 | 0.430 |
Why?
|
| Fetal Development | 6 | 2021 | 246 | 0.430 |
Why?
|
| Glutathione Disulfide | 2 | 2021 | 26 | 0.430 |
Why?
|
| Transcriptome | 4 | 2022 | 727 | 0.430 |
Why?
|
| Quality Control | 3 | 2022 | 144 | 0.430 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2023 | 689 | 0.430 |
Why?
|
| Photosynthesis | 1 | 2013 | 76 | 0.420 |
Why?
|
| Hemostatics | 2 | 2023 | 47 | 0.420 |
Why?
|
| Acclimatization | 4 | 2018 | 150 | 0.420 |
Why?
|
| Homeodomain Proteins | 4 | 2020 | 463 | 0.410 |
Why?
|
| Endothelium, Vascular | 5 | 2021 | 843 | 0.410 |
Why?
|
| Chronic Disease | 2 | 2017 | 1590 | 0.410 |
Why?
|
| Serpins | 3 | 2022 | 26 | 0.410 |
Why?
|
| Plateletpheresis | 3 | 2019 | 25 | 0.410 |
Why?
|
| MicroRNAs | 6 | 2018 | 601 | 0.410 |
Why?
|
| Lipids | 6 | 2023 | 582 | 0.410 |
Why?
|
| Critical Illness | 1 | 2017 | 643 | 0.410 |
Why?
|
| Cells, Cultured | 17 | 2021 | 3890 | 0.400 |
Why?
|
| Calcium | 6 | 2023 | 1103 | 0.400 |
Why?
|
| Chromatography, Liquid | 4 | 2019 | 348 | 0.400 |
Why?
|
| Parenteral Nutrition | 3 | 2021 | 96 | 0.400 |
Why?
|
| Fibroblasts | 5 | 2021 | 838 | 0.390 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 110 | 0.390 |
Why?
|
| Plasticizers | 3 | 2023 | 12 | 0.390 |
Why?
|
| Blastocyst | 1 | 2011 | 44 | 0.390 |
Why?
|
| Food Safety | 1 | 2011 | 16 | 0.390 |
Why?
|
| Stress, Physiological | 2 | 2018 | 379 | 0.390 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2020 | 288 | 0.390 |
Why?
|
| Retina | 1 | 2014 | 263 | 0.390 |
Why?
|
| Dietary Proteins | 1 | 2012 | 123 | 0.380 |
Why?
|
| Cell Proliferation | 14 | 2023 | 2196 | 0.380 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2021 | 193 | 0.380 |
Why?
|
| Erythrocyte Count | 2 | 2021 | 19 | 0.380 |
Why?
|
| Transplantation, Autologous | 3 | 2023 | 176 | 0.370 |
Why?
|
| Lung Diseases | 1 | 2017 | 696 | 0.370 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2009 | 160 | 0.370 |
Why?
|
| Reactive Nitrogen Species | 1 | 2011 | 21 | 0.370 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 182 | 0.370 |
Why?
|
| Docosahexaenoic Acids | 1 | 2011 | 69 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 2097 | 0.370 |
Why?
|
| Anemia | 2 | 2023 | 144 | 0.370 |
Why?
|
| Pregnancy | 17 | 2022 | 5525 | 0.370 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2023 | 123 | 0.370 |
Why?
|
| Kidney Failure, Chronic | 4 | 2016 | 487 | 0.360 |
Why?
|
| Interleukin-1 | 3 | 2021 | 966 | 0.360 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2022 | 249 | 0.360 |
Why?
|
| Blood Glucose | 4 | 2020 | 1821 | 0.360 |
Why?
|
| Brain | 8 | 2021 | 2374 | 0.360 |
Why?
|
| Medicine | 1 | 2012 | 102 | 0.360 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 1314 | 0.360 |
Why?
|
| Young Adult | 17 | 2022 | 10463 | 0.360 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2023 | 511 | 0.350 |
Why?
|
| Oxygen Consumption | 5 | 2021 | 588 | 0.350 |
Why?
|
| NF-kappa B | 5 | 2021 | 636 | 0.350 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2020 | 501 | 0.350 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 113 | 0.350 |
Why?
|
| Food | 1 | 2011 | 160 | 0.350 |
Why?
|
| Egg Proteins | 1 | 2010 | 19 | 0.350 |
Why?
|
| Dendritic Cells | 4 | 2021 | 436 | 0.350 |
Why?
|
| STAT3 Transcription Factor | 2 | 2022 | 173 | 0.350 |
Why?
|
| Proteolysis | 4 | 2020 | 143 | 0.350 |
Why?
|
| Urinary Diversion | 1 | 2009 | 11 | 0.340 |
Why?
|
| Pyruvates | 4 | 2023 | 20 | 0.340 |
Why?
|
| Flavones | 2 | 2019 | 10 | 0.340 |
Why?
|
| Tissue and Organ Procurement | 5 | 2016 | 228 | 0.340 |
Why?
|
| Nitric Oxide | 4 | 2022 | 824 | 0.340 |
Why?
|
| Transcription Factors | 3 | 2023 | 1528 | 0.330 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 149 | 0.330 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 305 | 0.330 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2023 | 119 | 0.330 |
Why?
|
| Neutrophils | 6 | 2022 | 1163 | 0.330 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2023 | 225 | 0.330 |
Why?
|
| Tryptophan Oxygenase | 3 | 2018 | 22 | 0.320 |
Why?
|
| Fetus | 4 | 2020 | 699 | 0.320 |
Why?
|
| Milk, Human | 1 | 2010 | 128 | 0.320 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 2 | 2020 | 13 | 0.320 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2021 | 182 | 0.320 |
Why?
|
| Sex Characteristics | 6 | 2023 | 640 | 0.320 |
Why?
|
| Nitriles | 2 | 2020 | 151 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 436 | 0.310 |
Why?
|
| Genome-Wide Association Study | 3 | 2023 | 1197 | 0.310 |
Why?
|
| Platelet Function Tests | 2 | 2020 | 24 | 0.310 |
Why?
|
| Alanine Transaminase | 4 | 2023 | 141 | 0.310 |
Why?
|
| Obesity | 6 | 2021 | 2513 | 0.310 |
Why?
|
| Models, Molecular | 4 | 2021 | 1378 | 0.310 |
Why?
|
| Isoantibodies | 2 | 2023 | 57 | 0.300 |
Why?
|
| Gestational Age | 5 | 2022 | 759 | 0.300 |
Why?
|
| Nanoparticles | 2 | 2022 | 313 | 0.300 |
Why?
|
| Inflammasomes | 2 | 2020 | 115 | 0.300 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 385 | 0.300 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 2 | 2017 | 14 | 0.290 |
Why?
|
| Maternal Exposure | 2 | 2019 | 138 | 0.290 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2017 | 18 | 0.290 |
Why?
|
| Lung | 8 | 2023 | 3546 | 0.290 |
Why?
|
| Nitrogen Isotopes | 2 | 2017 | 55 | 0.290 |
Why?
|
| Hypertension | 4 | 2021 | 1059 | 0.290 |
Why?
|
| Tumor Microenvironment | 5 | 2022 | 433 | 0.290 |
Why?
|
| Cell Survival | 7 | 2022 | 1021 | 0.290 |
Why?
|
| Lymphatic Vessels | 2 | 2020 | 54 | 0.290 |
Why?
|
| Genomics | 1 | 2012 | 639 | 0.290 |
Why?
|
| Phenotype | 10 | 2023 | 2812 | 0.290 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 176 | 0.290 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2018 | 63 | 0.290 |
Why?
|
| Macrophages, Alveolar | 2 | 2021 | 347 | 0.290 |
Why?
|
| Cell Line | 10 | 2023 | 2639 | 0.290 |
Why?
|
| Carbon Isotopes | 2 | 2017 | 112 | 0.290 |
Why?
|
| Multiple Sclerosis | 2 | 2023 | 380 | 0.290 |
Why?
|
| Graft Rejection | 10 | 2016 | 516 | 0.280 |
Why?
|
| Thrombelastography | 3 | 2023 | 175 | 0.280 |
Why?
|
| Membrane Proteins | 3 | 2023 | 1022 | 0.280 |
Why?
|
| Cysteine | 2 | 2019 | 171 | 0.280 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2017 | 53 | 0.280 |
Why?
|
| Cell Cycle Proteins | 4 | 2022 | 552 | 0.280 |
Why?
|
| Interferons | 3 | 2023 | 151 | 0.280 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2017 | 43 | 0.280 |
Why?
|
| Spermidine | 2 | 2024 | 17 | 0.280 |
Why?
|
| Hyperaldosteronism | 2 | 2019 | 8 | 0.280 |
Why?
|
| Microglia | 3 | 2023 | 202 | 0.280 |
Why?
|
| Cholesterol | 4 | 2023 | 368 | 0.270 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 284 | 0.270 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 2386 | 0.270 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2016 | 413 | 0.270 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2016 | 49 | 0.270 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2021 | 168 | 0.270 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 2763 | 0.270 |
Why?
|
| Familial Primary Pulmonary Hypertension | 2 | 2017 | 190 | 0.270 |
Why?
|
| Cytokines | 8 | 2023 | 1843 | 0.270 |
Why?
|
| Insulin Resistance | 3 | 2021 | 1072 | 0.270 |
Why?
|
| Blood Safety | 3 | 2017 | 10 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 450 | 0.260 |
Why?
|
| Anaerobiosis | 4 | 2017 | 49 | 0.260 |
Why?
|
| Solutions | 4 | 2018 | 146 | 0.260 |
Why?
|
| Lipoproteins | 3 | 2021 | 160 | 0.260 |
Why?
|
| Drosophila | 2 | 2024 | 133 | 0.260 |
Why?
|
| Isotonic Solutions | 2 | 2016 | 38 | 0.260 |
Why?
|
| Aged | 20 | 2023 | 19094 | 0.260 |
Why?
|
| Urea | 3 | 2023 | 68 | 0.260 |
Why?
|
| Case-Control Studies | 7 | 2022 | 3005 | 0.250 |
Why?
|
| Down Syndrome | 2 | 2021 | 338 | 0.250 |
Why?
|
| Cell Hypoxia | 3 | 2022 | 220 | 0.250 |
Why?
|
| Graft Survival | 15 | 2016 | 452 | 0.250 |
Why?
|
| Organ Preservation | 8 | 1999 | 64 | 0.250 |
Why?
|
| Cell Self Renewal | 3 | 2021 | 49 | 0.250 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 1521 | 0.250 |
Why?
|
| Mice, Inbred NOD | 7 | 2021 | 561 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2022 | 797 | 0.250 |
Why?
|
| Interleukin-2 | 2 | 2023 | 417 | 0.250 |
Why?
|
| In Vitro Techniques | 4 | 2021 | 1013 | 0.250 |
Why?
|
| RNA | 2 | 2023 | 810 | 0.250 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 7 | 2015 | 101 | 0.250 |
Why?
|
| Biological Transport | 3 | 2018 | 372 | 0.240 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 107 | 0.240 |
Why?
|
| Gene Expression | 5 | 2022 | 1420 | 0.240 |
Why?
|
| Lysine | 4 | 2019 | 242 | 0.240 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2018 | 158 | 0.240 |
Why?
|
| Random Allocation | 2 | 2023 | 335 | 0.240 |
Why?
|
| Mitochondria, Muscle | 4 | 2021 | 93 | 0.240 |
Why?
|
| Reference Standards | 2 | 2017 | 159 | 0.240 |
Why?
|
| Multiple Myeloma | 2 | 2023 | 93 | 0.240 |
Why?
|
| Phosphoproteins | 3 | 2023 | 299 | 0.240 |
Why?
|
| Computational Biology | 3 | 2014 | 530 | 0.240 |
Why?
|
| Inflammation Mediators | 4 | 2021 | 476 | 0.240 |
Why?
|
| Mice, Transgenic | 8 | 2022 | 1951 | 0.230 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2023 | 84 | 0.230 |
Why?
|
| Listeriosis | 2 | 2021 | 61 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2023 | 799 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1147 | 0.230 |
Why?
|
| Pyruvic Acid | 3 | 2021 | 42 | 0.230 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2023 | 123 | 0.230 |
Why?
|
| Thrombocythemia, Essential | 1 | 2024 | 6 | 0.230 |
Why?
|
| Machine Learning | 3 | 2023 | 318 | 0.230 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.230 |
Why?
|
| Immunomodulation | 2 | 2022 | 84 | 0.230 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2021 | 125 | 0.230 |
Why?
|
| Amino Acid Sequence | 4 | 2019 | 1988 | 0.230 |
Why?
|
| Hydroxyurea | 1 | 2023 | 30 | 0.230 |
Why?
|
| Cell Respiration | 6 | 2021 | 75 | 0.230 |
Why?
|
| Myeloproliferative Disorders | 1 | 2024 | 26 | 0.220 |
Why?
|
| C-Reactive Protein | 3 | 2022 | 362 | 0.220 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2023 | 21 | 0.220 |
Why?
|
| Reticulocytes | 1 | 2023 | 16 | 0.220 |
Why?
|
| Hexokinase | 1 | 2023 | 11 | 0.220 |
Why?
|
| Listeria monocytogenes | 2 | 2021 | 111 | 0.220 |
Why?
|
| Microchip Analytical Procedures | 1 | 2023 | 5 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2019 | 213 | 0.220 |
Why?
|
| AMP Deaminase | 1 | 2023 | 9 | 0.220 |
Why?
|
| Phthalic Acids | 1 | 2023 | 28 | 0.220 |
Why?
|
| NADP | 4 | 2021 | 43 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2022 | 271 | 0.220 |
Why?
|
| Epithelial Cells | 3 | 2021 | 955 | 0.220 |
Why?
|
| Insulin | 10 | 2021 | 2079 | 0.220 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 25 | 0.220 |
Why?
|
| Dietary Supplements | 4 | 2022 | 460 | 0.220 |
Why?
|
| Limb Buds | 1 | 2023 | 20 | 0.220 |
Why?
|
| Infant Behavior | 2 | 2020 | 23 | 0.220 |
Why?
|
| Osmotic Pressure | 2 | 2020 | 28 | 0.220 |
Why?
|
| Africa South of the Sahara | 1 | 2023 | 35 | 0.220 |
Why?
|
| Succinates | 1 | 2023 | 18 | 0.220 |
Why?
|
| Macrophage Activation | 2 | 2021 | 164 | 0.220 |
Why?
|
| Protein C | 1 | 2023 | 45 | 0.220 |
Why?
|
| Pteridines | 1 | 2023 | 20 | 0.220 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2022 | 201 | 0.220 |
Why?
|
| Quantitative Trait Loci | 2 | 2022 | 307 | 0.220 |
Why?
|
| Giant Cell Arteritis | 1 | 2023 | 48 | 0.210 |
Why?
|
| Glutamic Acid | 3 | 2017 | 211 | 0.210 |
Why?
|
| Hematopoiesis | 3 | 2021 | 172 | 0.210 |
Why?
|
| Fructose | 1 | 2023 | 100 | 0.210 |
Why?
|
| Carbon Dioxide | 2 | 2015 | 218 | 0.210 |
Why?
|
| Vinblastine | 1 | 2023 | 62 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2022 | 115 | 0.210 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 14 | 0.210 |
Why?
|
| Thrombophilia | 1 | 2023 | 66 | 0.210 |
Why?
|
| Sirtuin 3 | 1 | 2023 | 52 | 0.210 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2023 | 93 | 0.210 |
Why?
|
| Protein Kinase C-delta | 1 | 2023 | 70 | 0.210 |
Why?
|
| Multiple Trauma | 1 | 2023 | 89 | 0.210 |
Why?
|
| Radiation Tolerance | 1 | 2023 | 92 | 0.210 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2017 | 319 | 0.210 |
Why?
|
| Spectrin | 1 | 2022 | 13 | 0.210 |
Why?
|
| Fibrinogen | 3 | 2023 | 154 | 0.210 |
Why?
|
| src-Family Kinases | 1 | 2023 | 88 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 1361 | 0.210 |
Why?
|
| Imines | 1 | 2022 | 7 | 0.210 |
Why?
|
| Valosin Containing Protein | 1 | 2022 | 6 | 0.200 |
Why?
|
| Erythroblasts | 1 | 2022 | 12 | 0.200 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 115 | 0.200 |
Why?
|
| Gene Regulatory Networks | 4 | 2014 | 228 | 0.200 |
Why?
|
| Complement C4 | 1 | 2022 | 25 | 0.200 |
Why?
|
| Electron Transport Complex II | 2 | 2019 | 23 | 0.200 |
Why?
|
| Aldehydes | 1 | 2023 | 142 | 0.200 |
Why?
|
| Mice, SCID | 5 | 2021 | 320 | 0.200 |
Why?
|
| Bicycling | 1 | 2023 | 85 | 0.200 |
Why?
|
| Histiocytosis | 1 | 2022 | 8 | 0.200 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2022 | 76 | 0.200 |
Why?
|
| Hydrogen Peroxide | 2 | 2021 | 287 | 0.200 |
Why?
|
| Cohort Studies | 6 | 2023 | 4901 | 0.200 |
Why?
|
| Escherichia coli Proteins | 1 | 2023 | 162 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 2099 | 0.200 |
Why?
|
| Horses | 1 | 2022 | 96 | 0.200 |
Why?
|
| Balloon Occlusion | 1 | 2022 | 26 | 0.200 |
Why?
|
| Coagulants | 2 | 2012 | 12 | 0.200 |
Why?
|
| Pancreas Transplantation | 7 | 2000 | 61 | 0.200 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2022 | 10 | 0.200 |
Why?
|
| Adipose Tissue | 3 | 2017 | 539 | 0.200 |
Why?
|
| Benzoquinones | 1 | 2022 | 44 | 0.200 |
Why?
|
| RNA, Viral | 2 | 2023 | 566 | 0.200 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2021 | 235 | 0.200 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 10 | 0.200 |
Why?
|
| Blast Injuries | 1 | 2022 | 42 | 0.200 |
Why?
|
| Biological Products | 2 | 2022 | 167 | 0.200 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2022 | 21 | 0.200 |
Why?
|
| Erdheim-Chester Disease | 1 | 2021 | 5 | 0.200 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2021 | 8 | 0.200 |
Why?
|
| Factor VIII | 2 | 2012 | 54 | 0.200 |
Why?
|
| Kidney | 5 | 2022 | 1184 | 0.200 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2022 | 41 | 0.200 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2021 | 6 | 0.190 |
Why?
|
| Biogenic Amines | 1 | 2021 | 4 | 0.190 |
Why?
|
| Antimalarials | 1 | 2021 | 24 | 0.190 |
Why?
|
| Blood | 1 | 2022 | 96 | 0.190 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 34 | 0.190 |
Why?
|
| Persea | 1 | 2021 | 1 | 0.190 |
Why?
|
| Athletes | 2 | 2022 | 328 | 0.190 |
Why?
|
| Aurora Kinase B | 1 | 2021 | 8 | 0.190 |
Why?
|
| Recombinant Proteins | 2 | 2022 | 1233 | 0.190 |
Why?
|
| Isoxazoles | 1 | 2021 | 52 | 0.190 |
Why?
|
| Malaria, Falciparum | 1 | 2021 | 25 | 0.190 |
Why?
|
| Resistance Training | 1 | 2023 | 113 | 0.190 |
Why?
|
| Polyketides | 1 | 2021 | 3 | 0.190 |
Why?
|
| Phytosterols | 1 | 2021 | 11 | 0.190 |
Why?
|
| Breathing Exercises | 1 | 2021 | 18 | 0.190 |
Why?
|
| Primates | 2 | 2023 | 111 | 0.190 |
Why?
|
| Thyroid Hormones | 1 | 2021 | 54 | 0.190 |
Why?
|
| Inhalation | 1 | 2021 | 26 | 0.190 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 46 | 0.190 |
Why?
|
| Respiratory Muscles | 1 | 2021 | 28 | 0.190 |
Why?
|
| Sphingolipids | 2 | 2021 | 57 | 0.190 |
Why?
|
| Lipid Bilayers | 1 | 2022 | 99 | 0.190 |
Why?
|
| Dogs | 1 | 2022 | 334 | 0.190 |
Why?
|
| Glutaredoxins | 1 | 2021 | 11 | 0.190 |
Why?
|
| Myelopoiesis | 1 | 2021 | 6 | 0.190 |
Why?
|
| Methylation | 2 | 2018 | 208 | 0.190 |
Why?
|
| Cannabidiol | 1 | 2022 | 60 | 0.190 |
Why?
|
| Cyst Fluid | 1 | 2021 | 27 | 0.190 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2021 | 411 | 0.190 |
Why?
|
| Aniline Compounds | 1 | 2021 | 70 | 0.190 |
Why?
|
| Cell Tracking | 1 | 2021 | 13 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 229 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 122 | 0.180 |
Why?
|
| Virulence Factors | 1 | 2022 | 139 | 0.180 |
Why?
|
| Auditory Pathways | 1 | 2021 | 53 | 0.180 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 2791 | 0.180 |
Why?
|
| Sheep | 2 | 2020 | 764 | 0.180 |
Why?
|
| Syndecan-1 | 1 | 2020 | 27 | 0.180 |
Why?
|
| Erythrocyte Indices | 3 | 2018 | 28 | 0.180 |
Why?
|
| Maneb | 1 | 2020 | 7 | 0.180 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2020 | 9 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 189 | 0.180 |
Why?
|
| Gelsolin | 2 | 2014 | 9 | 0.180 |
Why?
|
| Seroconversion | 1 | 2021 | 45 | 0.180 |
Why?
|
| Pyrazines | 1 | 2021 | 71 | 0.180 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2021 | 89 | 0.180 |
Why?
|
| Cell Plasticity | 1 | 2021 | 23 | 0.180 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2022 | 117 | 0.180 |
Why?
|
| Sodium Nitrite | 1 | 2021 | 37 | 0.180 |
Why?
|
| Azacitidine | 2 | 2018 | 129 | 0.180 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 250 | 0.180 |
Why?
|
| Benzothiazoles | 2 | 2017 | 33 | 0.180 |
Why?
|
| Polymorphism, Genetic | 1 | 2023 | 612 | 0.180 |
Why?
|
| Cannabinoids | 1 | 2022 | 115 | 0.180 |
Why?
|
| Cell Nucleus | 3 | 2018 | 554 | 0.180 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 80 | 0.180 |
Why?
|
| Cystine | 1 | 2020 | 14 | 0.180 |
Why?
|
| Membrane Transport Proteins | 2 | 2023 | 138 | 0.180 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 521 | 0.180 |
Why?
|
| Cadaver | 8 | 2009 | 299 | 0.180 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 95 | 0.180 |
Why?
|
| Ammonia | 1 | 2020 | 56 | 0.180 |
Why?
|
| Antigens, Neoplasm | 2 | 2014 | 222 | 0.180 |
Why?
|
| Least-Squares Analysis | 2 | 2021 | 70 | 0.180 |
Why?
|
| Staining and Labeling | 1 | 2021 | 134 | 0.180 |
Why?
|
| Cellular Microenvironment | 1 | 2021 | 78 | 0.180 |
Why?
|
| Electron Transport Chain Complex Proteins | 2 | 2019 | 18 | 0.180 |
Why?
|
| Lipase | 1 | 2020 | 57 | 0.180 |
Why?
|
| Protein Unfolding | 1 | 2020 | 31 | 0.180 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 89 | 0.180 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 92 | 0.180 |
Why?
|
| Preoperative Period | 2 | 2019 | 103 | 0.180 |
Why?
|
| Creatine | 1 | 2020 | 50 | 0.180 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 51 | 0.180 |
Why?
|
| Feces | 2 | 2019 | 374 | 0.180 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 68 | 0.180 |
Why?
|
| Databases, Genetic | 1 | 2021 | 206 | 0.180 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 58 | 0.170 |
Why?
|
| Neutropenia | 1 | 2020 | 125 | 0.170 |
Why?
|
| Thrombin | 4 | 2023 | 139 | 0.170 |
Why?
|
| Glioblastoma | 1 | 2022 | 253 | 0.170 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 128 | 0.170 |
Why?
|
| Phenylurea Compounds | 2 | 2017 | 84 | 0.170 |
Why?
|
| Escherichia coli | 1 | 2023 | 722 | 0.170 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 263 | 0.170 |
Why?
|
| Antigens, CD34 | 2 | 2010 | 89 | 0.170 |
Why?
|
| TCF Transcription Factors | 1 | 2019 | 20 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 121 | 0.170 |
Why?
|
| Iron Overload | 1 | 2019 | 9 | 0.170 |
Why?
|
| Infant, Newborn | 8 | 2022 | 5035 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2021 | 127 | 0.170 |
Why?
|
| RNA, Messenger | 4 | 2022 | 2557 | 0.170 |
Why?
|
| Shock | 1 | 2020 | 75 | 0.170 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 193 | 0.170 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 23 | 0.170 |
Why?
|
| Lisinopril | 1 | 2019 | 13 | 0.170 |
Why?
|
| Phosphatidylserines | 1 | 2020 | 87 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2019 | 31 | 0.170 |
Why?
|
| Superoxides | 2 | 2017 | 214 | 0.170 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 2019 | 15 | 0.170 |
Why?
|
| HEK293 Cells | 5 | 2021 | 593 | 0.170 |
Why?
|
| Radiosurgery | 1 | 2022 | 302 | 0.170 |
Why?
|
| Sirtuins | 1 | 2019 | 32 | 0.170 |
Why?
|
| Histones | 2 | 2022 | 536 | 0.170 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2018 | 54 | 0.170 |
Why?
|
| DNA Methylation | 2 | 2022 | 496 | 0.170 |
Why?
|
| Liver Neoplasms | 3 | 2016 | 507 | 0.170 |
Why?
|
| Iron, Dietary | 1 | 2019 | 19 | 0.170 |
Why?
|
| Receptors, Interferon | 1 | 2019 | 47 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 103 | 0.170 |
Why?
|
| Chromium Radioisotopes | 1 | 2019 | 3 | 0.170 |
Why?
|
| Sensory Gating | 1 | 2019 | 38 | 0.170 |
Why?
|
| Hallucinogens | 1 | 2021 | 73 | 0.170 |
Why?
|
| Child Development | 2 | 2021 | 387 | 0.170 |
Why?
|
| Factor XIIIa | 1 | 2019 | 5 | 0.170 |
Why?
|
| Cell Membrane | 2 | 2022 | 679 | 0.170 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 262 | 0.160 |
Why?
|
| Macaca mulatta | 1 | 2019 | 131 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 706 | 0.160 |
Why?
|
| Leukopoiesis | 1 | 2019 | 10 | 0.160 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2019 | 15 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2020 | 147 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2021 | 6217 | 0.160 |
Why?
|
| Prescription Drugs | 1 | 2021 | 116 | 0.160 |
Why?
|
| Essential Hypertension | 1 | 2019 | 3 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2019 | 42 | 0.160 |
Why?
|
| NADPH Oxidase 2 | 1 | 2019 | 42 | 0.160 |
Why?
|
| Peptide Mapping | 1 | 2019 | 60 | 0.160 |
Why?
|
| Motor Activity | 1 | 2024 | 640 | 0.160 |
Why?
|
| Trisomy | 1 | 2019 | 68 | 0.160 |
Why?
|
| Mevalonic Acid | 1 | 2018 | 7 | 0.160 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2019 | 10 | 0.160 |
Why?
|
| Diet, High-Fat | 4 | 2022 | 225 | 0.160 |
Why?
|
| Pharmaceutical Solutions | 1 | 2019 | 14 | 0.160 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 20 | 0.160 |
Why?
|
| Oxidoreductases | 1 | 2019 | 92 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2020 | 72 | 0.160 |
Why?
|
| RNA Cleavage | 1 | 2018 | 7 | 0.160 |
Why?
|
| Transcription Termination, Genetic | 1 | 2018 | 12 | 0.160 |
Why?
|
| RNA Precursors | 1 | 2020 | 136 | 0.160 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2016 | 71 | 0.160 |
Why?
|
| Lipopolysaccharides | 5 | 2021 | 812 | 0.160 |
Why?
|
| Hepatocytes | 4 | 2021 | 196 | 0.160 |
Why?
|
| Fibrin | 1 | 2019 | 65 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2018 | 473 | 0.160 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2018 | 20 | 0.160 |
Why?
|
| Creatinine | 1 | 2020 | 424 | 0.160 |
Why?
|
| Acute Disease | 1 | 2021 | 912 | 0.160 |
Why?
|
| Click Chemistry | 1 | 2019 | 48 | 0.160 |
Why?
|
| Enzyme Activation | 4 | 2023 | 787 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 521 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 343 | 0.160 |
Why?
|
| Oxidants | 1 | 2019 | 112 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 112 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2020 | 245 | 0.150 |
Why?
|
| Coenzymes | 1 | 2018 | 16 | 0.150 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 184 | 0.150 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2018 | 11 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 20 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 524 | 0.150 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2018 | 22 | 0.150 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 22 | 0.150 |
Why?
|
| Vaccines, Subunit | 1 | 2018 | 42 | 0.150 |
Why?
|
| Endovascular Procedures | 1 | 2022 | 268 | 0.150 |
Why?
|
| Placental Insufficiency | 1 | 2019 | 102 | 0.150 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 28 | 0.150 |
Why?
|
| Diagnosis | 1 | 2018 | 9 | 0.150 |
Why?
|
| Therapeutics | 1 | 2018 | 12 | 0.150 |
Why?
|
| Deamination | 1 | 2017 | 5 | 0.150 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 45 | 0.150 |
Why?
|
| Premature Birth | 1 | 2021 | 276 | 0.150 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2018 | 77 | 0.150 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2017 | 13 | 0.150 |
Why?
|
| Hemoglobin A | 1 | 2017 | 21 | 0.150 |
Why?
|
| Blood Pressure | 2 | 2021 | 1530 | 0.150 |
Why?
|
| Genetic Variation | 2 | 2020 | 876 | 0.150 |
Why?
|
| Vascular Diseases | 1 | 2020 | 230 | 0.150 |
Why?
|
| Diglycerides | 1 | 2018 | 54 | 0.150 |
Why?
|
| Infant | 8 | 2020 | 7935 | 0.150 |
Why?
|
| Hydroxylamine | 1 | 2017 | 8 | 0.150 |
Why?
|
| Benzeneacetamides | 1 | 2017 | 7 | 0.150 |
Why?
|
| Crush Injuries | 1 | 2017 | 10 | 0.150 |
Why?
|
| Neurons | 4 | 2021 | 1281 | 0.150 |
Why?
|
| Liquid-Liquid Extraction | 1 | 2017 | 15 | 0.150 |
Why?
|
| Glutaminase | 1 | 2017 | 10 | 0.150 |
Why?
|
| Analysis of Variance | 2 | 2018 | 1226 | 0.150 |
Why?
|
| Nicotine | 1 | 2020 | 265 | 0.150 |
Why?
|
| Linear Models | 2 | 2017 | 770 | 0.150 |
Why?
|
| Cluster Analysis | 2 | 2016 | 460 | 0.150 |
Why?
|
| Freezing | 1 | 2017 | 85 | 0.150 |
Why?
|
| Glycogen | 1 | 2017 | 51 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 386 | 0.150 |
Why?
|
| Vitreous Body | 1 | 2018 | 101 | 0.150 |
Why?
|
| Swine, Miniature | 1 | 2017 | 71 | 0.150 |
Why?
|
| Thiadiazoles | 1 | 2017 | 21 | 0.150 |
Why?
|
| Retinal Detachment | 1 | 2018 | 53 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1435 | 0.150 |
Why?
|
| Carrier Proteins | 1 | 2021 | 696 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 323 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2022 | 452 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 48 | 0.140 |
Why?
|
| Immune System | 1 | 2018 | 173 | 0.140 |
Why?
|
| Limit of Detection | 1 | 2017 | 53 | 0.140 |
Why?
|
| Anxiety | 1 | 2023 | 842 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2018 | 244 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2021 | 1958 | 0.140 |
Why?
|
| Culture Media | 2 | 2021 | 155 | 0.140 |
Why?
|
| Femoral Fractures | 1 | 2017 | 67 | 0.140 |
Why?
|
| Specimen Handling | 2 | 2021 | 156 | 0.140 |
Why?
|
| Cystathionine | 1 | 2016 | 25 | 0.140 |
Why?
|
| Acute Lung Injury | 2 | 2017 | 298 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2018 | 1086 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2019 | 220 | 0.140 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 172 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 448 | 0.140 |
Why?
|
| Periodicity | 1 | 2016 | 55 | 0.140 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2018 | 141 | 0.140 |
Why?
|
| Basigin | 1 | 2017 | 25 | 0.140 |
Why?
|
| Mammals | 3 | 2023 | 245 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2024 | 330 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 337 | 0.140 |
Why?
|
| Health Status | 2 | 2019 | 723 | 0.140 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 1745 | 0.140 |
Why?
|
| Riboflavin | 2 | 2014 | 7 | 0.140 |
Why?
|
| Protein Folding | 1 | 2018 | 239 | 0.140 |
Why?
|
| Isoenzymes | 1 | 2017 | 285 | 0.140 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 40 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 93 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1699 | 0.130 |
Why?
|
| Color | 2 | 2019 | 74 | 0.130 |
Why?
|
| DNA | 1 | 2023 | 1351 | 0.130 |
Why?
|
| Diabetic Retinopathy | 1 | 2018 | 149 | 0.130 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2016 | 38 | 0.130 |
Why?
|
| Folic Acid | 1 | 2017 | 161 | 0.130 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 254 | 0.130 |
Why?
|
| Discriminant Analysis | 1 | 2016 | 37 | 0.130 |
Why?
|
| Parkinson Disease | 1 | 2020 | 345 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 312 | 0.130 |
Why?
|
| Bacteria | 1 | 2022 | 726 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 2539 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2020 | 572 | 0.130 |
Why?
|
| Succinate Dehydrogenase | 3 | 2022 | 42 | 0.130 |
Why?
|
| Extracellular Matrix | 2 | 2017 | 435 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 3 | 2023 | 854 | 0.130 |
Why?
|
| Body Temperature | 1 | 2016 | 208 | 0.130 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 35 | 0.130 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 429 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2019 | 335 | 0.130 |
Why?
|
| RNA Polymerase II | 1 | 2018 | 285 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 224 | 0.130 |
Why?
|
| Phosphatidylethanolamines | 1 | 2016 | 66 | 0.130 |
Why?
|
| Organ Transplantation | 3 | 1998 | 159 | 0.130 |
Why?
|
| Diet, Western | 3 | 2023 | 66 | 0.130 |
Why?
|
| Monocytes | 3 | 2023 | 503 | 0.130 |
Why?
|
| Sesquiterpenes | 2 | 2016 | 51 | 0.130 |
Why?
|
| Vasodilation | 1 | 2018 | 415 | 0.130 |
Why?
|
| Anoikis | 1 | 2015 | 31 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2021 | 723 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2022 | 134 | 0.130 |
Why?
|
| Hydroxylysine | 1 | 2015 | 4 | 0.130 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 39 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 1796 | 0.130 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 133 | 0.120 |
Why?
|
| Trauma Centers | 1 | 2017 | 325 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2021 | 41 | 0.120 |
Why?
|
| Drug Design | 2 | 2019 | 151 | 0.120 |
Why?
|
| Brassicaceae | 1 | 2015 | 9 | 0.120 |
Why?
|
| Taurocholic Acid | 1 | 2015 | 34 | 0.120 |
Why?
|
| Nijmegen Breakage Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
| Glycocalyx | 1 | 2015 | 18 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 4409 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2023 | 795 | 0.120 |
Why?
|
| RNA Interference | 4 | 2017 | 437 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 157 | 0.120 |
Why?
|
| Extinction, Biological | 1 | 2015 | 29 | 0.120 |
Why?
|
| Serine Proteases | 1 | 2014 | 14 | 0.120 |
Why?
|
| Europe | 1 | 2015 | 336 | 0.120 |
Why?
|
| Kallikreins | 1 | 2014 | 30 | 0.120 |
Why?
|
| Tissue Banks | 1 | 1994 | 18 | 0.120 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 64 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 984 | 0.120 |
Why?
|
| Vascular Remodeling | 3 | 2023 | 153 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 145 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2014 | 30 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 117 | 0.120 |
Why?
|
| Peptide Fragments | 3 | 2013 | 668 | 0.120 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 589 | 0.120 |
Why?
|
| Adolescent | 15 | 2022 | 17808 | 0.120 |
Why?
|
| Pilot Projects | 4 | 2022 | 1370 | 0.120 |
Why?
|
| Glycoproteins | 2 | 2013 | 304 | 0.120 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 503 | 0.120 |
Why?
|
| Seasons | 1 | 2016 | 450 | 0.120 |
Why?
|
| Phosphorylation | 5 | 2018 | 1571 | 0.120 |
Why?
|
| Cannabis | 1 | 2021 | 384 | 0.120 |
Why?
|
| Intestines | 1 | 2017 | 325 | 0.120 |
Why?
|
| Cations | 1 | 2014 | 79 | 0.120 |
Why?
|
| Placenta | 1 | 2020 | 626 | 0.120 |
Why?
|
| Sequence Deletion | 1 | 2014 | 167 | 0.120 |
Why?
|
| Neutrophil Activation | 1 | 2014 | 94 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 220 | 0.120 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 162 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 1134 | 0.120 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 78 | 0.120 |
Why?
|
| Parasitic Diseases | 1 | 2014 | 6 | 0.110 |
Why?
|
| Lipid Peroxidation | 1 | 2014 | 139 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 132 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2014 | 283 | 0.110 |
Why?
|
| Peptide Hydrolases | 1 | 2014 | 105 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 61 | 0.110 |
Why?
|
| Mothers | 4 | 2021 | 651 | 0.110 |
Why?
|
| Infant, Premature | 1 | 2017 | 478 | 0.110 |
Why?
|
| Peptides | 1 | 2019 | 848 | 0.110 |
Why?
|
| Adrenal Glands | 1 | 2014 | 67 | 0.110 |
Why?
|
| Tumor Protein p73 | 1 | 2013 | 14 | 0.110 |
Why?
|
| Ascorbic Acid | 1 | 2014 | 110 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2018 | 709 | 0.110 |
Why?
|
| Ultraviolet Rays | 2 | 2014 | 366 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2021 | 889 | 0.110 |
Why?
|
| Hyperplasia | 1 | 2014 | 163 | 0.110 |
Why?
|
| Epidermal Growth Factor | 2 | 2004 | 162 | 0.110 |
Why?
|
| Phosphatidylinositols | 1 | 2013 | 53 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2014 | 142 | 0.110 |
Why?
|
| Proteins | 3 | 2023 | 912 | 0.110 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2023 | 66 | 0.110 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 233 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 621 | 0.110 |
Why?
|
| Glucose Tolerance Test | 3 | 2021 | 343 | 0.110 |
Why?
|
| Up-Regulation | 3 | 2023 | 812 | 0.110 |
Why?
|
| Postmortem Changes | 1 | 2012 | 16 | 0.110 |
Why?
|
| Anticoagulants | 2 | 2023 | 547 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 91 | 0.110 |
Why?
|
| Collagen | 1 | 2015 | 415 | 0.110 |
Why?
|
| Photosensitizing Agents | 1 | 2013 | 26 | 0.100 |
Why?
|
| Erythropoiesis | 2 | 2023 | 34 | 0.100 |
Why?
|
| Diet | 1 | 2020 | 1080 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2016 | 289 | 0.100 |
Why?
|
| Larva | 3 | 2020 | 194 | 0.100 |
Why?
|
| Gamma Rays | 1 | 2013 | 48 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2014 | 180 | 0.100 |
Why?
|
| Interferon-alpha | 2 | 2004 | 187 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2013 | 255 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 935 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 413 | 0.100 |
Why?
|
| Taste Buds | 1 | 2015 | 209 | 0.100 |
Why?
|
| Doping in Sports | 1 | 2012 | 4 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2015 | 423 | 0.100 |
Why?
|
| Phosphoric Acids | 1 | 2012 | 16 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 637 | 0.100 |
Why?
|
| Stem Cells | 3 | 2021 | 546 | 0.100 |
Why?
|
| Peroxiredoxins | 1 | 2012 | 23 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1316 | 0.100 |
Why?
|
| Cell Extracts | 1 | 2012 | 15 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 140 | 0.100 |
Why?
|
| Adenoma | 1 | 2014 | 189 | 0.100 |
Why?
|
| Colorado | 2 | 2021 | 4086 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2013 | 257 | 0.100 |
Why?
|
| Genetic Background | 2 | 2021 | 8 | 0.100 |
Why?
|
| Multiple Organ Failure | 2 | 2022 | 142 | 0.100 |
Why?
|
| Embryo Culture Techniques | 1 | 2011 | 12 | 0.100 |
Why?
|
| Embryo Implantation | 1 | 2011 | 23 | 0.100 |
Why?
|
| Botrytis | 1 | 2011 | 1 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2014 | 195 | 0.100 |
Why?
|
| Resorcinols | 1 | 2011 | 4 | 0.100 |
Why?
|
| Wine | 1 | 2011 | 8 | 0.100 |
Why?
|
| Plant Diseases | 1 | 2011 | 32 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 388 | 0.100 |
Why?
|
| Crops, Agricultural | 1 | 2011 | 28 | 0.100 |
Why?
|
| Embryo Transfer | 1 | 2011 | 29 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 529 | 0.100 |
Why?
|
| Sus scrofa | 1 | 2011 | 45 | 0.100 |
Why?
|
| Trastuzumab | 2 | 2022 | 89 | 0.100 |
Why?
|
| Calibration | 1 | 2012 | 125 | 0.100 |
Why?
|
| Benzofurans | 1 | 2011 | 18 | 0.100 |
Why?
|
| Food Microbiology | 1 | 2011 | 57 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2018 | 192 | 0.100 |
Why?
|
| Protein Carbonylation | 1 | 2011 | 51 | 0.100 |
Why?
|
| Stilbenes | 1 | 2011 | 36 | 0.090 |
Why?
|
| Datasets as Topic | 2 | 2022 | 98 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 233 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 267 | 0.090 |
Why?
|
| Vitis | 1 | 2011 | 38 | 0.090 |
Why?
|
| Microbiota | 1 | 2018 | 648 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 400 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 498 | 0.090 |
Why?
|
| Bile Duct Diseases | 1 | 2011 | 15 | 0.090 |
Why?
|
| Survival Analysis | 5 | 2016 | 1218 | 0.090 |
Why?
|
| ABO Blood-Group System | 1 | 2011 | 32 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1846 | 0.090 |
Why?
|
| Living Donors | 3 | 2008 | 270 | 0.090 |
Why?
|
| Longevity | 2 | 2022 | 137 | 0.090 |
Why?
|
| Phenols | 1 | 2011 | 82 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2011 | 117 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 973 | 0.090 |
Why?
|
| Myofibrils | 2 | 2021 | 46 | 0.090 |
Why?
|
| Fertility | 1 | 2011 | 130 | 0.090 |
Why?
|
| Aquaporin 4 | 1 | 2011 | 87 | 0.090 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2021 | 44 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2010 | 59 | 0.090 |
Why?
|
| Retrospective Studies | 11 | 2022 | 12515 | 0.090 |
Why?
|
| Forecasting | 1 | 2012 | 331 | 0.090 |
Why?
|
| Neuronal Plasticity | 2 | 2023 | 209 | 0.090 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2021 | 35 | 0.090 |
Why?
|
| Pulmonary Artery | 3 | 2023 | 1012 | 0.090 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 543 | 0.090 |
Why?
|
| Injury Severity Score | 3 | 2018 | 456 | 0.090 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2010 | 4 | 0.090 |
Why?
|
| Nucleotides | 2 | 2023 | 112 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2022 | 3248 | 0.090 |
Why?
|
| Cell Shape | 1 | 2010 | 54 | 0.090 |
Why?
|
| Cell Size | 1 | 2010 | 80 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2011 | 629 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2011 | 174 | 0.080 |
Why?
|
| Protein Binding | 3 | 2020 | 1896 | 0.080 |
Why?
|
| Breeding | 1 | 2009 | 55 | 0.080 |
Why?
|
| Chickens | 1 | 2010 | 177 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2017 | 126 | 0.080 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2009 | 62 | 0.080 |
Why?
|
| Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.080 |
Why?
|
| United States | 4 | 2023 | 12176 | 0.080 |
Why?
|
| Fibrosis | 2 | 2023 | 453 | 0.080 |
Why?
|
| Treatment Outcome | 9 | 2021 | 9089 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2022 | 339 | 0.080 |
Why?
|
| Child | 12 | 2023 | 18352 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 1727 | 0.080 |
Why?
|
| Glucose Clamp Technique | 2 | 2021 | 181 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2023 | 198 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 1892 | 0.080 |
Why?
|
| Complement Activation | 2 | 2022 | 340 | 0.080 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2009 | 56 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2010 | 151 | 0.080 |
Why?
|
| Asthma | 1 | 2021 | 2032 | 0.080 |
Why?
|
| Metabolism | 2 | 2019 | 35 | 0.080 |
Why?
|
| Raffinose | 7 | 1999 | 18 | 0.080 |
Why?
|
| Cell Movement | 3 | 2017 | 867 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2023 | 1662 | 0.080 |
Why?
|
| Allopurinol | 7 | 1999 | 53 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2020 | 731 | 0.070 |
Why?
|
| Antagomirs | 2 | 2017 | 13 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 311 | 0.070 |
Why?
|
| Models, Animal | 2 | 2021 | 345 | 0.070 |
Why?
|
| Monocarboxylic Acid Transporters | 2 | 2017 | 21 | 0.070 |
Why?
|
| Heterozygote | 2 | 2021 | 251 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2021 | 310 | 0.070 |
Why?
|
| Ubiquitination | 2 | 2018 | 86 | 0.070 |
Why?
|
| Caspase 1 | 2 | 2018 | 140 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1691 | 0.070 |
Why?
|
| Sex Factors | 2 | 2023 | 1717 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2021 | 811 | 0.070 |
Why?
|
| Kinetics | 2 | 2022 | 1550 | 0.070 |
Why?
|
| GPI-Linked Proteins | 2 | 2017 | 54 | 0.070 |
Why?
|
| Spleen | 2 | 2019 | 484 | 0.070 |
Why?
|
| 5'-Nucleotidase | 2 | 2017 | 35 | 0.070 |
Why?
|
| Binding Sites | 2 | 2021 | 1176 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 347 | 0.070 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2018 | 227 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 2 | 2022 | 604 | 0.070 |
Why?
|
| Risk Factors | 5 | 2023 | 8627 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 2199 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2018 | 430 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2021 | 1013 | 0.070 |
Why?
|
| Platelet Activation | 2 | 2019 | 68 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2018 | 635 | 0.070 |
Why?
|
| Osmotic Fragility | 2 | 2018 | 6 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 528 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2021 | 722 | 0.060 |
Why?
|
| Glycerol | 2 | 2018 | 84 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2019 | 946 | 0.060 |
Why?
|
| Liver Diseases | 2 | 2021 | 254 | 0.060 |
Why?
|
| Sarcolemma | 2 | 2018 | 29 | 0.060 |
Why?
|
| Species Specificity | 3 | 2011 | 545 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2008 | 219 | 0.060 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2004 | 39 | 0.060 |
Why?
|
| Indoleacetic Acids | 1 | 2024 | 4 | 0.060 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 31 | 0.060 |
Why?
|
| Disease Progression | 2 | 2023 | 2387 | 0.060 |
Why?
|
| Fish Oils | 1 | 2023 | 21 | 0.060 |
Why?
|
| Respiratory Therapy | 1 | 2023 | 19 | 0.060 |
Why?
|
| Dapsone | 1 | 2023 | 5 | 0.060 |
Why?
|
| Maltose | 1 | 2023 | 5 | 0.060 |
Why?
|
| A549 Cells | 1 | 2023 | 51 | 0.060 |
Why?
|
| Metabolic Engineering | 1 | 2023 | 24 | 0.060 |
Why?
|
| Peptide Initiation Factors | 1 | 2003 | 17 | 0.050 |
Why?
|
| Monitoring, Immunologic | 1 | 2023 | 23 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2023 | 30 | 0.050 |
Why?
|
| Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2023 | 29 | 0.050 |
Why?
|
| Factor XIII | 1 | 2023 | 7 | 0.050 |
Why?
|
| Factor V | 1 | 2023 | 22 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2023 | 71 | 0.050 |
Why?
|
| Dasatinib | 1 | 2023 | 46 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2023 | 40 | 0.050 |
Why?
|
| Heme | 1 | 2023 | 52 | 0.050 |
Why?
|
| Guanine | 1 | 2003 | 76 | 0.050 |
Why?
|
| Sildenafil Citrate | 1 | 2023 | 57 | 0.050 |
Why?
|
| 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2022 | 5 | 0.050 |
Why?
|
| Postoperative Complications | 7 | 2000 | 2127 | 0.050 |
Why?
|
| Hand Strength | 1 | 2023 | 95 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 155 | 0.050 |
Why?
|
| Blood Coagulation Tests | 1 | 2023 | 57 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2022 | 16 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2023 | 126 | 0.050 |
Why?
|
| Leukocytes | 2 | 2017 | 277 | 0.050 |
Why?
|
| Inosine | 1 | 2022 | 11 | 0.050 |
Why?
|
| Myocardium | 2 | 2019 | 908 | 0.050 |
Why?
|
| Arginase | 1 | 2022 | 27 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 3 | 0.050 |
Why?
|
| RNA Splicing Factors | 1 | 2023 | 49 | 0.050 |
Why?
|
| Volunteers | 1 | 2022 | 31 | 0.050 |
Why?
|
| PQQ Cofactor | 1 | 2022 | 5 | 0.050 |
Why?
|
| Malates | 1 | 2022 | 5 | 0.050 |
Why?
|
| Citrulline | 1 | 2022 | 39 | 0.050 |
Why?
|
| Fumarates | 1 | 2022 | 10 | 0.050 |
Why?
|
| Quality of Life | 3 | 2023 | 2358 | 0.050 |
Why?
|
| Muscles | 1 | 2023 | 320 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2022 | 52 | 0.050 |
Why?
|
| Carboxylic Acids | 1 | 2022 | 26 | 0.050 |
Why?
|
| Solute Carrier Family 22 Member 5 | 1 | 2022 | 4 | 0.050 |
Why?
|
| Thyroid Nodule | 1 | 2002 | 38 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 57 | 0.050 |
Why?
|
| Ovarian Follicle | 1 | 1982 | 61 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2022 | 66 | 0.050 |
Why?
|
| Adipocytes | 1 | 2023 | 188 | 0.050 |
Why?
|
| Solvents | 1 | 2002 | 105 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2022 | 57 | 0.050 |
Why?
|
| Catalase | 1 | 2022 | 117 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 57 | 0.050 |
Why?
|
| Spermine | 1 | 2022 | 26 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2021 | 44 | 0.050 |
Why?
|
| Disease Resistance | 1 | 2021 | 27 | 0.050 |
Why?
|
| Caspases | 2 | 2018 | 245 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 399 | 0.050 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 33 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2021 | 84 | 0.050 |
Why?
|
| Ketone Oxidoreductases | 1 | 2021 | 7 | 0.050 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2021 | 3 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2023 | 237 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2021 | 61 | 0.050 |
Why?
|
| Phospholipids | 1 | 2023 | 197 | 0.050 |
Why?
|
| Plasmodium falciparum | 1 | 2021 | 27 | 0.050 |
Why?
|
| Comorbidity | 3 | 2021 | 1449 | 0.050 |
Why?
|
| Child, Preschool | 6 | 2021 | 9079 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 214 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2021 | 94 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2021 | 19 | 0.050 |
Why?
|
| Glycine | 1 | 2022 | 152 | 0.050 |
Why?
|
| Nephritis | 1 | 2021 | 20 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2019 | 193 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2022 | 124 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2021 | 157 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 195 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 153 | 0.050 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2021 | 21 | 0.050 |
Why?
|
| Wechsler Scales | 1 | 2021 | 52 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2022 | 142 | 0.050 |
Why?
|
| Albuminuria | 1 | 2022 | 164 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2021 | 91 | 0.050 |
Why?
|
| Ranitidine | 1 | 2021 | 13 | 0.050 |
Why?
|
| Transplantation, Homologous | 4 | 2011 | 386 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2021 | 129 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2021 | 9 | 0.050 |
Why?
|
| Social Problems | 1 | 2021 | 11 | 0.050 |
Why?
|
| Oncogenes | 1 | 2021 | 107 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2021 | 32 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2021 | 17 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 359 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2021 | 47 | 0.050 |
Why?
|
| Hypoalbuminemia | 1 | 2021 | 26 | 0.050 |
Why?
|
| gamma-Glutamyl Hydrolase | 1 | 2020 | 2 | 0.050 |
Why?
|
| Candidiasis | 1 | 2021 | 52 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2021 | 78 | 0.050 |
Why?
|
| Phenylephrine | 1 | 2021 | 71 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2023 | 303 | 0.050 |
Why?
|
| Arctic Regions | 1 | 2020 | 17 | 0.050 |
Why?
|
| Access to Information | 1 | 2021 | 47 | 0.050 |
Why?
|
| Behavior Observation Techniques | 1 | 2020 | 9 | 0.050 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2020 | 31 | 0.050 |
Why?
|
| Granulocytes | 1 | 2021 | 78 | 0.050 |
Why?
|
| Erucic Acids | 1 | 2020 | 2 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 121 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 105 | 0.050 |
Why?
|
| Presenilin-1 | 1 | 2020 | 27 | 0.050 |
Why?
|
| Serum Response Factor | 1 | 2021 | 28 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2023 | 270 | 0.050 |
Why?
|
| Ovary | 1 | 1982 | 191 | 0.050 |
Why?
|
| Linoleic Acid | 1 | 2021 | 38 | 0.050 |
Why?
|
| Spatial Memory | 1 | 2020 | 17 | 0.050 |
Why?
|
| Action Potentials | 1 | 2023 | 406 | 0.050 |
Why?
|
| Hematologic Tests | 1 | 2020 | 22 | 0.050 |
Why?
|
| Point Mutation | 1 | 2021 | 216 | 0.050 |
Why?
|
| Psoriasis | 1 | 2021 | 74 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 493 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2020 | 33 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 138 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 305 | 0.050 |
Why?
|
| Bacteriophage lambda | 1 | 2021 | 81 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2021 | 90 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 71 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 54 | 0.050 |
Why?
|
| Ferritins | 1 | 2020 | 52 | 0.050 |
Why?
|
| Platelet Aggregation | 1 | 2021 | 94 | 0.050 |
Why?
|
| Lipogenesis | 1 | 2021 | 57 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2021 | 201 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 1151 | 0.040 |
Why?
|
| Intelligence | 1 | 2021 | 131 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 299 | 0.040 |
Why?
|
| Biomimetic Materials | 1 | 2021 | 64 | 0.040 |
Why?
|
| Patient Selection | 3 | 2015 | 641 | 0.040 |
Why?
|
| Data Mining | 1 | 2021 | 100 | 0.040 |
Why?
|
| Astrocytes | 1 | 2022 | 162 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 164 | 0.040 |
Why?
|
| Fat Body | 1 | 2020 | 4 | 0.040 |
Why?
|
| Cochlea | 1 | 2021 | 90 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2020 | 67 | 0.040 |
Why?
|
| Nootropic Agents | 1 | 2020 | 27 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 25 | 0.040 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 148 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2020 | 77 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 211 | 0.040 |
Why?
|
| Exome | 1 | 2021 | 200 | 0.040 |
Why?
|
| Niacinamide | 1 | 2020 | 64 | 0.040 |
Why?
|
| Phylogeny | 1 | 2023 | 794 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 207 | 0.040 |
Why?
|
| Object Attachment | 1 | 2020 | 33 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 105 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 157 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 56 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2001 | 211 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2020 | 396 | 0.040 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 31 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 77 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2021 | 286 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2001 | 228 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 19 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2021 | 184 | 0.040 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2019 | 44 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 356 | 0.040 |
Why?
|
| DNA Damage | 1 | 2022 | 357 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2021 | 177 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2019 | 30 | 0.040 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2019 | 3 | 0.040 |
Why?
|
| Technetium | 1 | 2019 | 8 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 584 | 0.040 |
Why?
|
| Carbocyanines | 1 | 2019 | 30 | 0.040 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2019 | 6 | 0.040 |
Why?
|
| Alanine | 1 | 2019 | 104 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2021 | 180 | 0.040 |
Why?
|
| Wisconsin | 2 | 2001 | 91 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2023 | 475 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2019 | 19 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 139 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 2021 | 301 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2018 | 8 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2018 | 10 | 0.040 |
Why?
|
| Water | 1 | 2022 | 399 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 180 | 0.040 |
Why?
|
| Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 128 | 0.040 |
Why?
|
| 3' Flanking Region | 1 | 2018 | 7 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 312 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2019 | 124 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 791 | 0.040 |
Why?
|
| Tricarboxylic Acids | 1 | 2018 | 10 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 130 | 0.040 |
Why?
|
| Terpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 71 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 28 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 188 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2018 | 20 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 2020 | 177 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 117 | 0.040 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
|
| Vaccinia | 1 | 2018 | 18 | 0.040 |
Why?
|
| Macaca | 1 | 2018 | 50 | 0.040 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2018 | 32 | 0.040 |
Why?
|
| Ataxia Telangiectasia | 1 | 2018 | 17 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2019 | 80 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 77 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 83 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 47 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 564 | 0.040 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2018 | 14 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 183 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2018 | 62 | 0.040 |
Why?
|
| Inpatients | 1 | 2022 | 378 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2024 | 574 | 0.040 |
Why?
|
| Thioredoxins | 1 | 2018 | 33 | 0.040 |
Why?
|
| Caspases, Initiator | 1 | 2018 | 18 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 42 | 0.040 |
Why?
|
| Liver X Receptors | 1 | 2018 | 30 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 489 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2021 | 368 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2018 | 161 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 342 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 383 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 295 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2018 | 74 | 0.040 |
Why?
|
| Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
|
| Ethanol | 1 | 2002 | 548 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6350 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2001 | 413 | 0.040 |
Why?
|
| Dopamine | 1 | 2020 | 236 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 14 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 171 | 0.040 |
Why?
|
| Methods | 1 | 2017 | 58 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 743 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 2017 | 45 | 0.040 |
Why?
|
| Lim Kinases | 1 | 2017 | 5 | 0.040 |
Why?
|
| Smad5 Protein | 1 | 2017 | 7 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2020 | 255 | 0.040 |
Why?
|
| Smad1 Protein | 1 | 2017 | 18 | 0.040 |
Why?
|
| Naphthoquinones | 1 | 2017 | 17 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 815 | 0.040 |
Why?
|
| Logistic Models | 1 | 2022 | 1843 | 0.040 |
Why?
|
| Glycogen Phosphorylase | 1 | 2017 | 4 | 0.040 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 154 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 114 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 863 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 65 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 381 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 460 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 48 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 133 | 0.040 |
Why?
|
| Pyrroles | 1 | 2018 | 183 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 52 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2018 | 197 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2020 | 565 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 437 | 0.040 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2017 | 34 | 0.040 |
Why?
|
| Cytosol | 1 | 2018 | 208 | 0.040 |
Why?
|
| Microcirculation | 1 | 2017 | 135 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 4420 | 0.040 |
Why?
|
| Transfusion Reaction | 1 | 2017 | 65 | 0.040 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2017 | 23 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2018 | 159 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2017 | 130 | 0.040 |
Why?
|
| Solubility | 1 | 2017 | 224 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2018 | 206 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2011 | 286 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2018 | 145 | 0.040 |
Why?
|
| Attention | 1 | 2020 | 394 | 0.030 |
Why?
|
| Drug Overdose | 1 | 2021 | 292 | 0.030 |
Why?
|
| Weaning | 1 | 2016 | 48 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2017 | 81 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2022 | 739 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 562 | 0.030 |
Why?
|
| Interleukins | 1 | 2018 | 236 | 0.030 |
Why?
|
| Hydrazines | 1 | 2016 | 28 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 6 | 0.030 |
Why?
|
| Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2016 | 8 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 43 | 0.030 |
Why?
|
| Tacrolimus | 1 | 1997 | 134 | 0.030 |
Why?
|
| Interleukin-18 | 1 | 2018 | 219 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 39 | 0.030 |
Why?
|
| Myoblasts | 1 | 2017 | 76 | 0.030 |
Why?
|
| Triglycerides | 1 | 2018 | 470 | 0.030 |
Why?
|
| Fetal Hemoglobin | 1 | 2016 | 6 | 0.030 |
Why?
|
| Indoles | 1 | 2018 | 306 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 59 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 33 | 0.030 |
Why?
|
| Adventitia | 1 | 2016 | 37 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 85 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 554 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 130 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 140 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2016 | 56 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 188 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 1997 | 85 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2019 | 378 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2017 | 261 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 271 | 0.030 |
Why?
|
| Donor Selection | 1 | 2016 | 66 | 0.030 |
Why?
|
| Blood Viscosity | 1 | 2015 | 16 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 234 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 135 | 0.030 |
Why?
|
| Drainage | 2 | 1993 | 151 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 646 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2019 | 560 | 0.030 |
Why?
|
| Bison | 1 | 2015 | 6 | 0.030 |
Why?
|
| Cholangiocarcinoma | 1 | 1995 | 38 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2015 | 81 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 140 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 181 | 0.030 |
Why?
|
| Blood Circulation | 1 | 2015 | 34 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 429 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2015 | 84 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 319 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 774 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 609 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2017 | 213 | 0.030 |
Why?
|
| X-Rays | 1 | 2014 | 30 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 321 | 0.030 |
Why?
|
| Allergens | 1 | 2018 | 413 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 130 | 0.030 |
Why?
|
| Elasticity | 1 | 2015 | 189 | 0.030 |
Why?
|
| Postoperative Care | 2 | 1993 | 219 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 194 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2015 | 68 | 0.030 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1994 | 4 | 0.030 |
Why?
|
| Body Size | 1 | 2015 | 91 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2020 | 814 | 0.030 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1995 | 66 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2018 | 292 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 870 | 0.030 |
Why?
|
| Microscopy, Electrochemical, Scanning | 1 | 2014 | 1 | 0.030 |
Why?
|
| Arsenites | 1 | 2014 | 4 | 0.030 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2019 | 467 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 1774 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1133 | 0.030 |
Why?
|
| Tranexamic Acid | 1 | 2015 | 39 | 0.030 |
Why?
|
| Furocoumarins | 1 | 2014 | 8 | 0.030 |
Why?
|
| Homozygote | 1 | 2014 | 187 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1040 | 0.030 |
Why?
|
| Skull | 1 | 2015 | 119 | 0.030 |
Why?
|
| Exercise Test | 1 | 2017 | 544 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2016 | 281 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2014 | 20 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1994 | 171 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 445 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2016 | 313 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 176 | 0.030 |
Why?
|
| Hypertension, Portal | 1 | 1994 | 61 | 0.030 |
Why?
|
| Serine | 1 | 2014 | 126 | 0.030 |
Why?
|
| Adiposity | 1 | 2018 | 457 | 0.030 |
Why?
|
| Aldosterone | 1 | 2014 | 42 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2015 | 189 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 396 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 596 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 530 | 0.030 |
Why?
|
| Hemostasis | 1 | 2014 | 67 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 954 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 2013 | 33 | 0.030 |
Why?
|
| Urologic Diseases | 1 | 1993 | 35 | 0.030 |
Why?
|
| Photochemistry | 1 | 2014 | 125 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1996 | 221 | 0.030 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1993 | 17 | 0.030 |
Why?
|
| Registries | 2 | 2016 | 1759 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 139 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2017 | 386 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2014 | 216 | 0.030 |
Why?
|
| Tissue Preservation | 1 | 1992 | 12 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1214 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2012 | 44 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 1044 | 0.030 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 19 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 1752 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2012 | 40 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 566 | 0.020 |
Why?
|
| Drug Contamination | 1 | 2012 | 53 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 2011 | 17 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2012 | 331 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 545 | 0.020 |
Why?
|
| Survival Rate | 4 | 1999 | 1642 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 56 | 0.020 |
Why?
|
| Family | 1 | 1995 | 591 | 0.020 |
Why?
|
| Atracurium | 1 | 1991 | 13 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1995 | 283 | 0.020 |
Why?
|
| Complement C4b | 1 | 2011 | 9 | 0.020 |
Why?
|
| Dystrophin | 1 | 2011 | 30 | 0.020 |
Why?
|
| Conalbumin | 1 | 1990 | 3 | 0.020 |
Why?
|
| Hemophilia A | 1 | 2011 | 70 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 101 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1993 | 350 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2011 | 104 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 1991 | 89 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1991 | 164 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1989 | 58 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2008 | 86 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2008 | 103 | 0.020 |
Why?
|
| Incidence | 3 | 2001 | 2312 | 0.020 |
Why?
|
| Nephrectomy | 2 | 1998 | 149 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 936 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 63 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 236 | 0.010 |
Why?
|
| KB Cells | 1 | 2003 | 4 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 146 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 164 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2002 | 117 | 0.010 |
Why?
|
| Leucine | 1 | 1982 | 102 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 278 | 0.010 |
Why?
|
| Cysts | 1 | 2002 | 93 | 0.010 |
Why?
|
| Oocytes | 1 | 1982 | 171 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 276 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 759 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 181 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 291 | 0.010 |
Why?
|
| Age Factors | 2 | 1999 | 2890 | 0.010 |
Why?
|
| Muromonab-CD3 | 1 | 1998 | 20 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 1080 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2001 | 1176 | 0.010 |
Why?
|
| Mycophenolic Acid | 1 | 1998 | 77 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 362 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 145 | 0.010 |
Why?
|
| Bile | 1 | 1997 | 26 | 0.010 |
Why?
|
| Pancreas | 1 | 1999 | 277 | 0.010 |
Why?
|
| Potassium | 1 | 1997 | 128 | 0.010 |
Why?
|
| Sodium | 1 | 1997 | 182 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 168 | 0.010 |
Why?
|
| Splenectomy | 1 | 1996 | 51 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1996 | 118 | 0.010 |
Why?
|
| Diabetic Nephropathies | 2 | 1989 | 234 | 0.010 |
Why?
|
| Colectomy | 1 | 1995 | 86 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 385 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 647 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 221 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1996 | 369 | 0.010 |
Why?
|
| Employment | 1 | 1993 | 138 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 1991 | 38 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1991 | 52 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1990 | 122 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1991 | 317 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1993 | 406 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1989 | 330 | 0.000 |
Why?
|